Serum Institute to double investment in Biocon Biologics to $300 millionSerum Institute of Life Sciences (SILS) has converted a $150 million loan into equity, increasing its investment in Biocon Biologics. This ...
25 Apr, 2023, 08.27 PM IST
Serum Life Sciences to double investments in Biocon Biologics to $300 million under new arrangementUnder the fresh terms of their strategic alliance, Serum Life Sciences will make an additional equity investment of $150 million through th...
25 Apr, 2023, 10.40 AM IST
India's Serum to double investment in Biocon's unit to $300 mlnSerum Institute of Life Sciences is a unit of Serum Institute of India, the world's biggest vaccine maker. Under new terms of the alliance,...
25 Apr, 2023, 09.55 AM IST
Buy Biocon, target price Rs 375: JM FinancialBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 28934.46 Crore) operating in Pharmaceuticals secto...
02 Feb, 2023, 12.29 PM IST
Biocon Biologics appoints Shreehas Tambe as MD & CEOTambe has been with Biocon since 1997 and has held diverse leadership and operational roles. Over the past 25 years, he has helped build an...
05 Dec, 2022, 07.36 PM IST
Biocon completes $3.34 billion acquisition of Viatris's biosimilar businessTo fund the upfront payment, Biocon Biologics has secured $1.2 billion of Sustainability Linked Loan (SLL). The balance has been funded thr...
29 Nov, 2022, 07.24 PM IST
Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar businessThe transaction with US-based Viatris required regulatory approvals from the Reserve Bank of India, Competition Commission of India and the...
16 Nov, 2022, 11.04 AM IST
Biocon Biologics expects big gains from integration of Viatris business, SII dealBiocon Biologics in March entered into a definitive agreement to acquire Viatris' biosimilars assets for $3.34 billion. It will pay Viatris...
09 Jun, 2022, 12.36 AM IST
CCI clears Serum Institute Life Sciences-Biocon Biologics dealOnce the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to th...
18 May, 2022, 11.07 PM IST
Biocon Q4 Results: Profit declines 4% to Rs 283 crConsolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period, it...
28 Apr, 2022, 11.11 PM IST
Viatris deal pinches Biocon, but may prove a good betThe $3.3-billion acquisition - that includes $2.3 billion cash and a 12.9% equity stake in BBL - stands at over half of the market cap of B...
01 Mar, 2022, 10.05 AM IST
Serum Institute to invest $68 million in UK vaccine maker Oxford BiomedicaSerum Life Sciences Ltd, a unit of India-based SII, will pick up a 3.9% stake in Oxford Biomedica as part of the deal. Oxford Biomedica, sp...
22 Sep, 2021, 02.18 PM IST
Can Serum deal provide a booster dose to Biocon's target price?The Serum alliance would give Biocon Biologics' access to 100 million doses of vaccines per annum for 15 years with commercialisation right...
20 Sep, 2021, 12.00 PM IST
Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
18 Sep, 2021, 06.33 AM IST
Kiran Mazumdar-Shaw & Adar Poonawalla spell out the road map for Biocon-Serum alliance"The Biocon-Serum alliance will initially focus on Covid vaccines, because that is the need of the hour. At a later stage, we will see what...
17 Sep, 2021, 04.40 PM IST
Biocon unit plans 15% stake sale to Serum Institute for access to vaccinesThe deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the...
17 Sep, 2021, 03.56 PM IST
Biocon Biologics to offer 15% stake to Serum Institute Life SciencesUnder the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of th...
16 Sep, 2021, 11.38 PM IST